Community/Retail

Pharmacy Times and Parata Systems honored pharmacists at the 2015 Next-Generation Pharmacist® Awards gala at Universal Studios in Orlando, Florida, on August 6.

Heart Hospital of New Mexico at Lovelace Medical Center has received the American Heart Association's Mission: Lifeline Heart Attack Receiving Center Accreditation.

University of California, San Francisco, (UCSF) pharmacy students are being trained to recognize and address unconscious bias in the pharmacy.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Respiratory diseases affect millions worldwide and greatly burden the global health care system financially.

AstraZeneca and Heptares Therapeutics announced that they have entered a licensing agreement which AstraZeneca will acquire exclusive rights to develop the adenosine A2A receptor antagonist, HTL-1071.

Orexigen Therapeutics, Inc. and Takeda Pharmaceutical Company Limited today announced execution of an amended and restated collaboration agreement that resolves all outstanding disputes.

The Academy of Managed Care Pharmacy was included in an Aug. 6 blog entry from The White House Office of National AIDS Policy.

As the 2015 NACDS Total Store Expo nears, the National Association of Chain Drug Stores (NACDS) announces the return of the Online Press Room.

Disagreements between federal lawmakers about Tricare co-payments have delayed the passage of the 2016 National Defense Authorization Act (NDAA).

Bausch and Lomb's Victus femtosecond laser platform has received clearance from the FDA for an enhanced patient interface kit.

Scott A. Meyers, RPh, MS, FASHP, shares his thoughts on pharmacy technicians and their growing role within the pharmacy team.

They say a picture is worth a thousand words, but these pharmacist stock photos leave us with a thousand questions.

A team of researchers from around the country have published findings indicating the accuracy of MSPrecise®, a laboratory test under development for diagnosing MS.

Boston Medical Center has received a $1.3 million grant from the Agency for Healthcare Research and Quality to support a demonstration project of pharmacy-based naloxone rescue kits.

Within a few years of primary prevention defibrillator placement, one-quarter of heart failure (HF) patients show improvements in heart function above the clinical threshold.

Allergan plc and KYTHERA Biopharmaceuticals, Inc. today announced that they have amended and restated their merger agreement with respect to Allergan's pending acquisition of KYTHERA.

Pharmacists in Washington State can no longer cite religion to refuse to fill a prescription.

As part of its ongoing effort to reduce the risk of acetaminophen-related liver damage, the FDA has issued industry guidance for OTC pediatric oral liquid products containing acetaminophen.

To meet the needs of the rapidly growing number of pharmacists and student pharmacists who are seeking residencies, ASHP will hold a Second Residency Match beginning in March 2016.

The parents of a 4-year-old cancer survivor are claiming that 3 different Walgreens pharmacies refused to fill oxycodone prescriptions for their son.

straZeneca today announced that MedImmune, its global biologics research and development arm, has entered into an exclusive clinical trial collaboration with Mirati Therapeutics, Inc.

Empowering Americans to make better food choices is the goal of a breakthrough initiative between the American Heart Association.

Diabetics are at greater risk for viral and bacterial infection compared with the remainder of the population.

CVS Health Corporation has announced operating results for the 3 months ended June 30, 2015.

Continuing an estimated $750 million investment in Wisconsin, Meijer has opened 2 more stores in Wauwatosa and Oak Creek.

Bristol-Myers Squibb Company today announced a charitable donation to The Leukemia & Lymphoma Society (LLS).

While the University of Houston College of Pharmacy has historic roots, Dean F. Lamar Pritchard, PhD, RPh, is excited about a modern campus upgrade.

A permanent injunction has been issued by a federal judge against 3 dietary supplement companies.

The FDA is warning health care professionals about a rare brain infection seen in multiple sclerosis patients taking fingolimod (Gilenya).